Low Prostate Cancer-Specific Mortality Seen for Men With Localized Disease
Prostate cancer-specific mortality was low for men randomly assigned to active monitoring, prostatectomy, or radiotherapy.
Home
Initiative Increased BRCA Testing in Ovarian Cancer Patients
A multipronged initiative increased germline BRCA mutation testing for patients with ovarian cancer by 31%.
Performance Scores Predict Immune Checkpoint Inhibitor-Related Adverse Events
An analysis of data from patients with cancer treated with immune checkpoint inhibitors sought to determine predictors of immune-related adverse effects in these patients.
Characteristics, Treatment Options for Patients With Advanced Gynecologic Cancers
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
Update on Therapeutic Options for Myelofibrosis
A review of myelofibrosis, including an update on treatment options, was presented at the 2023 ONA Summit.
New Treatments, New Challenges in the Treatment of Bladder and Renal Cancers
A discussion of new treatment options that have improved prognosis for patients with bladder cancer and renal cell carcinoma is the focus of a presentation at the 2023 ONA Summit.
Advanced Gastric and Colorectal Cancer Diagnosis and Treatment
Management strategies aimed at improving outcomes in patients with CRC and gastric cancer were presented at the 2023 ONA Summit.
Treatment Selection and Symptom Management After MDS/MDN Diagnosis
A review of MDS/MDN, including new WHO guidelines and collaborative strategies for managing the care of patients with lower-risk MDS.
Pivotal Studies Lead to New Treatment Landscape for Metastatic HER2-Positive Breast Cancer
A review of patient assessment, treatment options, and management strategies for adverse effects in patients with metastatic HER2-positive breast cancer were presented at the 2023 ONA Summit.
Updates in Targeted Therapies, Management Strategies for Non-Small Cell Lung Cancer
In an oral presentation at the 2023 ONA Summit, a thoracic oncology nurse practitioner reviewed the advances in the treatment of NSCLC and management of related adverse effects.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in ONA Summit 2023
Loading... 
Loading...